Noradrenaline acting at central ?-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration
Evidence indicates that the monoamine neurotransmitter noradrenaline elicits anti-inflammatory actions in the central nervous system (CNS), and consequently may play a neuroprotective role where inflammatory events contribute to CNS pathology. Here we examined the ability of pharmacologically enhanc...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2010
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/25919
- Acceso en línea:
- https://doi.org/10.1016/j.bbi.2010.02.005
https://repository.urosario.edu.co/handle/10336/25919
- Palabra clave:
- IL-10
SOCS3
Noradrenaline
?-Adrenoceptor
STAT3
Brain
Anti-inflammatory
- Rights
- License
- Restringido (Acceso a grupos específicos)
id |
EDOCUR2_b7b64534a067dd357c8edcfa5f7394e3 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/25919 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
3f844d67-649f-4ce9-9c87-856fac92cd17-1f7645cc7-e4e8-40c4-8eaa-f4d5ba3e82d4-1a65095de-ce31-45f7-a6f3-1137e049e992-179942772600d294504c-410b-4f35-81a5-fcaea842c84d-18bb0c73f-2dc4-43a2-9560-5ad597e8f439-15049d76a-fcc5-4056-a98e-900b373e83f0-12020-08-06T16:20:13Z2020-08-06T16:20:13Z2010-05-01Evidence indicates that the monoamine neurotransmitter noradrenaline elicits anti-inflammatory actions in the central nervous system (CNS), and consequently may play a neuroprotective role where inflammatory events contribute to CNS pathology. Here we examined the ability of pharmacologically enhancing central noradrenergic tone to induce expression of anti-inflammatory cytokines in rat brain. Administration of the noradrenaline reuptake inhibitor reboxetine (15 mg/kg; ip) combined with the ?2-adrenoceptor antagonist idazoxan (1 mg/kg; ip) induced interleukin-10 (IL-10) expression in rat cortex and hippocampus. In addition, these drug treatments induced IL-10 signaling as indicated by increased STAT3 phosphorylation and suppressor of cytokine signaling-3 (SOCS-3) mRNA expression. In contrast to the profound increase in IL-10 induced by the reboxetine/idazoxan combination, the other two broad spectrum anti-inflammatory cytokines IL-4 and TGF-? were not induced by this treatment. The ability of combined treatment with reboxetine and idazoxan to induce IL-10 and SOCS3 expression was mediated by ?-adrenoceptor activation, as their induction was blocked by pre-treatment with the ?-adrenoceptor antagonist propranolol. Moreover, administration of the brain penetrant ?2-adrenoceptor agonist clenbuterol induced a time- and dose-dependent increase in central IL-10 and SOCS3 expression, and the ability of clenbuterol to induce IL-10 and SOCS-3 expression was blocked by the centrally acting ?-adrenoceptor antagonist, propranolol, and was mimicked by the highly selective ?2-adrenoceptor agonist formoterol. In all, these data indicate that increasing central noradrenergic tone induces IL-10 production and signaling in the CNS, which may protect against neurodegeneration.application/pdfhttps://doi.org/10.1016/j.bbi.2010.02.005ISSN: 0889-1591EISSN: 1090-2139https://repository.urosario.edu.co/handle/10336/25919engElsevier671No. 4660Brain, Behavior, and ImmunityVol. 24Brain, Behavior, and Immunity, ISSN: 0889-1591;EISSN: 1090-2139, Vol.24, No.4 (2010);pp.660-671https://www.sciencedirect.com/science/article/abs/pii/S0889159110000474?via%3DihubRestringido (Acceso a grupos específicos)http://purl.org/coar/access_right/c_16ecBrain, Behavior, and Immunityinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURIL-10SOCS3Noradrenaline?-AdrenoceptorSTAT3BrainAnti-inflammatoryNoradrenaline acting at central ?-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegenerationLa noradrenalina que actúa en los ?-adrenoceptores centrales induce la interleucina-10 y el supresor de la expresión de la citocina señalización-3 en el cerebro de rata: implicaciones para la neurodegeneraciónarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501McNameea, Eon N.Ryana, Karen M.Griffin, Éadaoin W.González Reyes, Rodrigo EstebanRyana, Katie J.Harkin, AndrewConnor, Thomas J.10336/25919oai:repository.urosario.edu.co:10336/259192022-05-02 07:37:21.725996https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Noradrenaline acting at central ?-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration |
dc.title.TranslatedTitle.spa.fl_str_mv |
La noradrenalina que actúa en los ?-adrenoceptores centrales induce la interleucina-10 y el supresor de la expresión de la citocina señalización-3 en el cerebro de rata: implicaciones para la neurodegeneración |
title |
Noradrenaline acting at central ?-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration |
spellingShingle |
Noradrenaline acting at central ?-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration IL-10 SOCS3 Noradrenaline ?-Adrenoceptor STAT3 Brain Anti-inflammatory |
title_short |
Noradrenaline acting at central ?-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration |
title_full |
Noradrenaline acting at central ?-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration |
title_fullStr |
Noradrenaline acting at central ?-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration |
title_full_unstemmed |
Noradrenaline acting at central ?-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration |
title_sort |
Noradrenaline acting at central ?-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration |
dc.subject.keyword.spa.fl_str_mv |
IL-10 SOCS3 Noradrenaline ?-Adrenoceptor STAT3 Brain Anti-inflammatory |
topic |
IL-10 SOCS3 Noradrenaline ?-Adrenoceptor STAT3 Brain Anti-inflammatory |
description |
Evidence indicates that the monoamine neurotransmitter noradrenaline elicits anti-inflammatory actions in the central nervous system (CNS), and consequently may play a neuroprotective role where inflammatory events contribute to CNS pathology. Here we examined the ability of pharmacologically enhancing central noradrenergic tone to induce expression of anti-inflammatory cytokines in rat brain. Administration of the noradrenaline reuptake inhibitor reboxetine (15 mg/kg; ip) combined with the ?2-adrenoceptor antagonist idazoxan (1 mg/kg; ip) induced interleukin-10 (IL-10) expression in rat cortex and hippocampus. In addition, these drug treatments induced IL-10 signaling as indicated by increased STAT3 phosphorylation and suppressor of cytokine signaling-3 (SOCS-3) mRNA expression. In contrast to the profound increase in IL-10 induced by the reboxetine/idazoxan combination, the other two broad spectrum anti-inflammatory cytokines IL-4 and TGF-? were not induced by this treatment. The ability of combined treatment with reboxetine and idazoxan to induce IL-10 and SOCS3 expression was mediated by ?-adrenoceptor activation, as their induction was blocked by pre-treatment with the ?-adrenoceptor antagonist propranolol. Moreover, administration of the brain penetrant ?2-adrenoceptor agonist clenbuterol induced a time- and dose-dependent increase in central IL-10 and SOCS3 expression, and the ability of clenbuterol to induce IL-10 and SOCS-3 expression was blocked by the centrally acting ?-adrenoceptor antagonist, propranolol, and was mimicked by the highly selective ?2-adrenoceptor agonist formoterol. In all, these data indicate that increasing central noradrenergic tone induces IL-10 production and signaling in the CNS, which may protect against neurodegeneration. |
publishDate |
2010 |
dc.date.created.spa.fl_str_mv |
2010-05-01 |
dc.date.accessioned.none.fl_str_mv |
2020-08-06T16:20:13Z |
dc.date.available.none.fl_str_mv |
2020-08-06T16:20:13Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1016/j.bbi.2010.02.005 |
dc.identifier.issn.none.fl_str_mv |
ISSN: 0889-1591 EISSN: 1090-2139 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/25919 |
url |
https://doi.org/10.1016/j.bbi.2010.02.005 https://repository.urosario.edu.co/handle/10336/25919 |
identifier_str_mv |
ISSN: 0889-1591 EISSN: 1090-2139 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
671 |
dc.relation.citationIssue.none.fl_str_mv |
No. 4 |
dc.relation.citationStartPage.none.fl_str_mv |
660 |
dc.relation.citationTitle.none.fl_str_mv |
Brain, Behavior, and Immunity |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 24 |
dc.relation.ispartof.spa.fl_str_mv |
Brain, Behavior, and Immunity, ISSN: 0889-1591;EISSN: 1090-2139, Vol.24, No.4 (2010);pp.660-671 |
dc.relation.uri.spa.fl_str_mv |
https://www.sciencedirect.com/science/article/abs/pii/S0889159110000474?via%3Dihub |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_16ec |
dc.rights.acceso.spa.fl_str_mv |
Restringido (Acceso a grupos específicos) |
rights_invalid_str_mv |
Restringido (Acceso a grupos específicos) http://purl.org/coar/access_right/c_16ec |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Elsevier |
dc.source.spa.fl_str_mv |
Brain, Behavior, and Immunity |
institution |
Universidad del Rosario |
dc.source.instname.none.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.none.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1831928209756651520 |